Total awarded
€13.4M
Award notices won
15
Lots won
21
Last award
Aug 10, 2026
Awarded lots
| Lot | CPV | Contract nature | Award value | Estimated value | Place | Award criteria |
|---|---|---|---|---|---|---|
LOT-0001 / B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP] | Pharmaceutical products | supplies | €4.92M | €4.92M | PRT | price |
LOT-0001 / B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP] | Pharmaceutical products | supplies | €2.79M | €2.79M | PRT | price |
LOT-0001 / E587 - EMTRICITABINA + RILPIVIRINA + TENOFOVIR ALAFENAMIDA [200 + 25 + 25 MG COMP] | Pharmaceutical products | supplies | €900,505 | €900,505 | PRT | price |
LOT-0001 / S1809 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] | Pharmaceutical products | supplies | €684,180 | €684,180 | PRT | price |
LOT-0001 / A492 - ANFOTERICINA B LIPOSSÓMICA [50MG IV F/AMP] | Pharmaceutical products | supplies | €478,287 | €478,287 | PRT | price |
LOT-0004 / RILPIVIRINA 25 MG COMP | Pharmaceutical products | supplies | €470,745 | €470,745 | - | price |
LOT-0004 / EMTRICITABINA 200 MG + RILPIVIRINA 25 MG + TENOFOVIR ALAFENAMIDA 25 MG COMP | Pharmaceutical products | supplies | €470,745 | €470,745 | - | price |
LOT-0002 / DARUNAVIR 800+COBICISTATE 150+EMTRICITABINA 200+TENOFOVIR ALAFENAMIDA10MGCOMP | Pharmaceutical products | supplies | €388,939 | €388,939 | - | price |
LOT-0001 / BICTEGRAVIR 50 MG + EMTRICITABINA 200 MG + TENOFOVIR ALAFENAMIDA 25 MG COMP | Various medicinal products | supplies | €370,412 | €370,412 | PRT / funchal | price |
LOT-0001 / BICTEGRAVIR 50 MG + EMTRICITABINA 200 MG + TENOFOVIR ALAFENAMIDA 25 MG COMP | Pharmaceutical products | supplies | €326,040 | €326,040 | - | price |
Show 11 more rows
LOT-0001 / A53306 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] | Pharmaceutical products | supplies | €273,088 | €273,088 | PRT | price |
LOT-0001 / A53306 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] | Pharmaceutical products | supplies | €273,088 | €273,088 | PRT | price |
LOT-0001 / A53306 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] | Pharmaceutical products | supplies | €273,088 | €273,088 | PRT | price |
LOT-0001 / S1809 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] | Pharmaceutical products | supplies | €164,203 | €164,203 | PRT | price |
LOT-0006 / EMTRICITABINA 200 MG + TENOFOVIR ALAFENAMIDA 25 MG COMP | Pharmaceutical products | supplies | €159,002 | €159,002 | - | price |
LOT-0001 / S1809 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] | Pharmaceutical products | supplies | €136,836 | €136,836 | PRT | price |
LOT-0001 / A492 - ANFOTERICINA B LIPOSSÓMICA [50MG IV F/AMP] | Pharmaceutical products | supplies | €132,612 | €132,612 | PRT | price |
LOT-0001 / A492 - ANFOTERICINA B LIPOSSÓMICA [50MG IV F/AMP] | Pharmaceutical products | supplies | €96,365 | €96,365 | PRT | price |
LOT-0003 / ETRAVIRINA 200 MG COMP | Pharmaceutical products | supplies | €21,672 | €21,672 | - | price |
LOT-0001 / DARUNAVIR 800 MG + COBICISTATE 150 MG COMP | Pharmaceutical products | supplies | €20,790 | €20,790 | - | price |
LOT-0002 / ELVITEGRAVIR + COBICISTATE + EMTRICITABINA+ TENOFOVIR 150MG+150MG+200MG+245MG | Pharmaceutical products | supplies | €4,716 | €4,716 | - | price |
Award tenders
| Tender | Buyer | Publication date | Procedure | Award date | Awarded to contractor | Lots won |
|---|---|---|---|---|---|---|
| ANTIVIRICOS - 3 MESES 473606-2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Jul 08, 2026 | restricted | Jul 07, 2026 | €370,412 | 1 |
| 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] 554102-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Aug 10, 2026 | restricted | Jun 04, 2026 | €273,088 | 1 |
| 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] 555227-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Aug 10, 2026 | restricted | Jun 04, 2026 | €273,088 | 1 |
| 2024/0900 - EMTRICITABINA + RILPIVIRINA + TENOFOVIR ALAFENAMIDA [200 + 25 + 25 MG COMP] 556866-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Aug 10, 2026 | restricted | May 13, 2026 | €900,505 | 1 |
| 2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP] 521471-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 27, 2026 | restricted | May 13, 2026 | €4.92M | 1 |
| 2025/1589 - ANFOTERICINA B LIPOSSÓMICA [50MG IV F/AMP] 502632-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 20, 2026 | restricted | May 13, 2026 | €478,287 | 1 |
| 2023/0481 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] 486736-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 13, 2026 | restricted | May 13, 2026 | €684,180 | 1 |
| 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] 554728-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Aug 10, 2026 | restricted | May 05, 2026 | €273,088 | 1 |
| 2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP] 520966-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 27, 2026 | restricted | Apr 22, 2026 | €2.79M | 1 |
| 2025/1589 - ANFOTERICINA B LIPOSSÓMICA [50MG IV F/AMP] 502332-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 20, 2026 | restricted | Mar 30, 2026 | €132,612 | 1 |
Show 5 more rows
| 2023/0481 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] 485103-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 13, 2026 | restricted | Feb 02, 2026 | €164,203 | 1 |
| 2025/1589 - ANFOTERICINA B LIPOSSÓMICA [50MG IV F/AMP] 503354-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 20, 2026 | restricted | Jan 30, 2026 | €96,365 | 1 |
| 2023/0481 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] 487007-2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Jul 13, 2026 | restricted | Jan 30, 2026 | €136,836 | 1 |
| ANTIVÍRICOS - 1º SEMESTRE 183518-2024 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Mar 27, 2024 | restricted | Mar 07, 2024 | €1.17M | 4 |
| ANTIVÍRICOS - 1º SEMESTRE 183789-2024 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Mar 27, 2024 | restricted | Jan 26, 2024 | €439,111 | 4 |
Company details
Identifiers
503604704
Countries
PRT
Cities
LISBOA
Post codes
1050-094
Emails
About this contractor
GILEAD SCIENCES, LDA is a contractor that has been awarded public procurement contracts published through official European procurement systems.
This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.
FAQ
What information does this contractor profile contain?
This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.
What does Total Awarded mean?
Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.
Why can the awarded value differ from the total contract value?
A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.
What are Awarded Lots?
Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.
How often is this profile updated?
Contractor profiles are updated automatically when new procurement notices and contract award notices become available.
Why are some company details missing?
Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.
Understanding this contractor profile
This contractor profile is generated from publicly available procurement information published by contracting authorities.
The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.
Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.